What is the equity of Fuso Pharmaceutical Industries this year?
Fuso Pharmaceutical Industries has equity of 36.66 B JPY this year.
In 2024, Fuso Pharmaceutical Industries's equity was 36.66 B JPY, a 6.17% increase from the 34.53 B JPY equity in the previous year.
Fuso Pharmaceutical Industries's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Fuso Pharmaceutical Industries's equity is essential for assessing its financial health, stability, and value to shareholders.
Evaluating Fuso Pharmaceutical Industries's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Fuso Pharmaceutical Industries's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Fluctuations in Fuso Pharmaceutical Industries’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Fuso Pharmaceutical Industries has equity of 36.66 B JPY this year.
The equity of Fuso Pharmaceutical Industries has increased/decreased by 6.17% increased compared to the previous year.
A high equity is advantageous for investors of Fuso Pharmaceutical Industries as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
A low equity can be a risk for investors of Fuso Pharmaceutical Industries, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
An increase in equity of Fuso Pharmaceutical Industries can strengthen the company's financial position and improve its ability to make investments in the future.
A reduction in equity of Fuso Pharmaceutical Industries can affect the financial situation of the company and lead to a higher dependence on debt capital.
Some factors that can affect the equity of Fuso Pharmaceutical Industries include profits, dividend payments, capital increases, and acquisitions.
The equity of Fuso Pharmaceutical Industries is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
To change equity, Fuso Pharmaceutical Industries can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
Over the past 12 months, Fuso Pharmaceutical Industries paid a dividend of 75 JPY . This corresponds to a dividend yield of about 3.42 %. For the coming 12 months, Fuso Pharmaceutical Industries is expected to pay a dividend of 75 JPY.
The current dividend yield of Fuso Pharmaceutical Industries is 3.42 %.
Fuso Pharmaceutical Industries pays a quarterly dividend. This is distributed in the months of October, April, October, April.
Fuso Pharmaceutical Industries paid dividends every year for the past 20 years.
For the upcoming 12 months, dividends amounting to 75 JPY are expected. This corresponds to a dividend yield of 3.42 %.
Fuso Pharmaceutical Industries is assigned to the 'Health' sector.
To receive the latest dividend of Fuso Pharmaceutical Industries from 12/1/2024 amounting to 40 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
The last dividend was paid out on 12/1/2024.
In the year 2023, Fuso Pharmaceutical Industries distributed 75 JPY as dividends.
The dividends of Fuso Pharmaceutical Industries are distributed in JPY.
Our stock analysis for Fuso Pharmaceutical Industries Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fuso Pharmaceutical Industries Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.